Approaches for 1L Therapy and Restaging in Triple-Positive mBC

Opinion
Video

Susan Dent, MD, delves into the exploration of front-line treatment options for triple-positive breast cancer and examines strategies for restaging in the event of disease progression after first-line therapy.

Recent Videos
Related Content
54 The Treatment of Breast Cancer With Percutaneous Thermal Ablation: Results of the THERMAC Trial

54 The Treatment of Breast Cancer With Percutaneous Thermal Ablation: Results of the THERMAC Trial

Linda Riks;Sophie Wooldrik;Taco Klem;Gerson Struik
May 21st 2025
Article
Findings highlight a need to incorporate diverse populations when developing guideline-concordant breast cancer care to achieve efficacy for all patients.

Eliminating Racial Disparities in Guideline-Concordant Breast Cancer Care

Oluwadamilola “Lola” Fayanju, MD, MA, MPHS, FACS
April 21st 2025
Podcast

Findings highlight a need to incorporate diverse populations when developing guideline-concordant breast cancer care to achieve efficacy for all patients.

55 Do Genetic Counseling and Testing Affect Rates of Contralateral Prophylactic Mastectomy in Patients Without Clinically Actionable Mutations?

55 Do Genetic Counseling and Testing Affect Rates of Contralateral Prophylactic Mastectomy in Patients Without Clinically Actionable Mutations?

Natalie Garver;Valerie L. Staradub, MD;Christopher Verdone;Kelly Mackessy;Alexandra Haraczy;Lianteng Zhi
May 20th 2025
Article
Paolo Tarantino, MD, and Matteo Lambertini, MD, PhD discuss findings related to CDK4/6 inhibitors and antibody drug conjugates presented at SABCS 2024.

SABCS 2024 Data Show ‘Great Steps Forward’ in Breast Cancer Care

Paolo Tarantino, MD;Matteo Lambertini, MD
January 13th 2025
Podcast

Paolo Tarantino, MD, and Matteo Lambertini, MD, PhD discuss findings related to CDK4/6 inhibitors and antibody drug conjugates presented at SABCS 2024.

57 Tumor Morphology Concordance in Multifocal/Multicentric Triple- Negative and HER2+ Breast Cancers

57 Tumor Morphology Concordance in Multifocal/Multicentric Triple- Negative and HER2+ Breast Cancers

Frances Phang;Anna Weiss, MD;Huina Zhang
May 18th 2025
Article
59 Are Choosing Wisely Guidelines Applicable to Patients With a High Ki-67 Proliferation Index and Magee Equation Score?

59 Are Choosing Wisely Guidelines Applicable to Patients With a High Ki-67 Proliferation Index and Magee Equation Score?

Leslie Elmore;Neil Carleton;Michael S. Cowher;Rohit Bhargava;Emilia Diego;Kristin Lupinacci;Meaghan Marley;Qurat Ul Ain Sabih;Atilla Soran, MD, MPH;Jennifer Steiman;Ronald Johnson;Erin Bayley;Priscilla F. Mcauliffe, MD, PhD
May 17th 2025
Article